Related Experiment Video
Updated: Jun 7, 2025

08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.7K
Apathy and Functional Status in Early-Stage Huntington's Disease
Jessie S Gibson1, Kaitlyn R Hay1, Daniel O Claassen1
1University of Virginia School of Nursing, Charlottesville (Gibson, Jiang); Department of Neurology, Vanderbilt University Medical Center, Nashville (Hay, Claassen, McDonell, Brown, Wynn, Isaacs).
The Journal of Neuropsychiatry and Clinical Neurosciences
|November 19, 2024
Summary
Apathy impacts functional status in Huntington's disease (HD). Addressing apathy can improve quality of life and well-being in early-stage HD patients.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Apathy is a prevalent and challenging symptom in Huntington's disease (HD).
- Understanding apathy's impact on functional status is crucial for HD clinical trials.
- Limited research exists on apathy's correlates and effects in early-stage HD.
Purpose of the Study:
- To identify factors associated with apathy in HD patients.
- To determine the effect of apathy on functional status in a primarily early-stage HD sample.
Main Methods:
- Secondary analysis of existing clinical HD data.
- Spearman correlation to assess relationships between apathy, clinical variables, and outcomes.
- Multiple regression analyses to evaluate apathy's impact on functional status measures (AFAB, TFC).
Main Results:
- Apathy correlated with lower quality of life (Neuro-QoL Satisfaction With Social Roles and Activities, Positive Affect and Well-Being).
- Apathy scores were significantly associated with both functional status measures (AFAB, TFC).
- Apathy explained significant variability in functional status in regression models.
Conclusions:
- Apathy significantly affects functional status, social satisfaction, and well-being in HD.
- Targeting apathy is essential for improving outcomes in individuals with early-stage HD.
- Further research and interventions addressing apathy are needed in HD management.
Related Concept Videos
Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482

